Heemers H - Search Results

1

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.

Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, Lee RJ, Logothetis CJ, Matusik R, Plymate S, Sawyers CL, Selth LA, Soule H, Tilley W, Weigel NL, Zoubeidi A, Dehm SM, Raj GV. Luo J, et al. Among authors: heemers h. Eur Urol. 2018 May;73(5):715-723. doi: 10.1016/j.eururo.2017.11.038. Epub 2017 Dec 16. Eur Urol. 2018. PMID: 29258679 Free PMC article. Review.

2

Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.

Heemers HV, Regan KM, Dehm SM, Tindall DJ. Heemers HV, et al. Cancer Res. 2007 Nov 1;67(21):10592-9. doi: 10.1158/0008-5472.CAN-07-1917. Cancer Res. 2007. PMID: 17975004

3

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ. Dehm SM, et al. Cancer Res. 2008 Jul 1;68(13):5469-77. doi: 10.1158/0008-5472.CAN-08-0594. Cancer Res. 2008. PMID: 18593950 Free PMC article.

4

Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.

Raclaw KA, Heemers HV, Kidd EM, Dehm SM, Tindall DJ. Raclaw KA, et al. Prostate. 2008 Nov 1;68(15):1696-706. doi: 10.1002/pros.20844. Prostate. 2008. PMID: 18726983 Free PMC article.

5

Unraveling the complexities of androgen receptor signaling in prostate cancer cells.

Heemers HV, Tindall DJ. Heemers HV, et al. Cancer Cell. 2009 Apr 7;15(4):245-7. doi: 10.1016/j.ccr.2009.03.009. Cancer Cell. 2009. PMID: 19345321 Free PMC article.

6

Androgen action in the prostate gland.

Yadav N, Heemers HV. Yadav N, et al. Among authors: heemers hv. Minerva Urol Nefrol. 2012 Mar;64(1):35-49. Minerva Urol Nefrol. 2012. PMID: 22402316 Review.

7

Alternative approaches to prevent androgen action in prostate cancer: are we there yet?

Elbanna M, Heemers HV. Elbanna M, et al. Discov Med. 2014 May;17(95):267-74. Discov Med. 2014. PMID: 24882718 Free article.

8

Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?

Heemers HV. Heemers HV. Int J Biol Sci. 2014 Jun 1;10(6):576-87. doi: 10.7150/ijbs.8479. eCollection 2014. Int J Biol Sci. 2014. PMID: 24948870 Free PMC article. Review.

9

Words of wisdom. Re: Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents.

Heemers HV, Mohler JL. Heemers HV, et al. Eur Urol. 2014 Sep;66(3):597. doi: 10.1016/j.eururo.2014.06.032. Eur Urol. 2014. PMID: 25306183 Free PMC article. No abstract available.

10

Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.

Wei L, Wang J, Lampert E, Schlanger S, DePriest AD, Hu Q, Gomez EC, Murakam M, Glenn ST, Conroy J, Morrison C, Azabdaftari G, Mohler JL, Liu S, Heemers HV. Wei L, et al. Eur Urol. 2017 Feb;71(2):183-192. doi: 10.1016/j.eururo.2016.07.008. Epub 2016 Jul 21. Eur Urol. 2017. PMID: 27451135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page